Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

658 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators. Imaizumi S, et al. Among authors: matsunaga a. Heart Vessels. 2019 Apr;34(4):698-710. doi: 10.1007/s00380-018-1286-2. Epub 2018 Nov 8. Heart Vessels. 2019. PMID: 30406819 Clinical Trial.
Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators. Imaizumi S, et al. Among authors: matsunaga a. Heart Vessels. 2020 Apr;35(4):603-604. doi: 10.1007/s00380-019-01374-5. Heart Vessels. 2020. PMID: 30972549
Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study.
Zhang B, Miura S, Yanagi D, Noda K, Nishikawa H, Matsunaga A, Shirai K, Iwata A, Yoshinaga K, Adachi H, Imaizumi T, Saku K. Zhang B, et al. Among authors: matsunaga a. Atherosclerosis. 2008 Dec;201(2):353-9. doi: 10.1016/j.atherosclerosis.2008.02.024. Epub 2008 Mar 2. Atherosclerosis. 2008. PMID: 18395728 Clinical Trial.
658 results